1-2 of 2
Vivian Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Promising response rates and manageable safety with mosunetuzumab plus lenalidomide (Mosun-Len) in patients with relapsed/refractory (R/R) follicular lymphoma (FL): US extension cohort from the Phase III CELESTIMO study

Free
Dahlia Sano, Nancy Bartlett, Elizabeth Budde, Brett Brinker, Rakhee Vaidya, Sunil Babu, Catherine Diefenbach, Chijioke Nze, Connie Ma, Andrea Knapp, Michelle Doral, Vivian Chen, Paloma Hauser, Michael C. Wei, Pretibha Moorthy, Anna Phillips, Natalie Surh, Adam Jan, Enkhtsetseg Purev, Nina Wagner-Johnston
Journal: Blood
Blood (2025) 146 (Supplement 1): 1800.
https://doi.org/10.1182/blood-2025-1800
Published: 2025
Journal Articles

Preliminary Findings of a Phase Ib/II Trial Indicate Manageable Safety and Promising Efficacy for Mosunetuzumab in Combination with Lenalidomide (M+Len) in Previously Untreated (1L) Follicular Lymphoma (FL)

Free
Franck Morschhauser, Krish Patel, Sabela Bobillo, Raul Cordoba, Toby A. Eyre, Mark Bishton, Roch Houot, Hui-Lai Zhang, Liqun Zou, Wendy Osborne, Laura Gálvez-Carvajal, Catherine Thieblemont, Donald Yee, Andrea Knapp, Enkhtsetseg Purev, Haocheng Li, Vivian Chen, Karl L. Banta, Jason Sit, Emmanuel Bachy
Journal: Blood
Blood (2023) 142 (Supplement 1): 605.
https://doi.org/10.1182/blood-2023-174432
Published: 2023